Source: EURLEX
Language: en
Format: md

[**Avis juridique important**](../../../editorial/legal_notice.htm)

*|*

# 92001E2090

**WRITTEN QUESTION E-2090/01 by Jens-Peter Bonde (EDD) to the Commission. The Sixth Framework Programme for Research in the EU.** 
  
*Official Journal 040 E , 14/02/2002 P. 0183 - 0184*

  

WRITTEN QUESTION E-2090/01

by Jens-Peter Bonde (EDD) to the Commission

(13 July 2001)

Subject: The Sixth Framework Programme for Research in the EU

Why has research into diseases been scaled down under the Sixth Framework Programme for Research, and why have certain diseases been left out of the programme altogether?

Answer given by Mr Busquin on behalf of the Commission

(24 September 2001)

The Commission does not envisage that disease-related research will be scaled down under the next Framework Programme compared to the Fifth Framework Programme for Research and technological development. The proposed budget should actually increase the amount of funding available for such research.

Disease-related research will be supported strongly in the Specific Programme Integrating and Strengthening the European Research Area within all areas of the priority theme 1.1.1 Genomics and Biotechnology for Health.

In particular, the following will be addressed under the research priorities listed below:

(i) Fundamental knowledge and basic tools for functional genomics, tools and approaches will be developed, which will lead to a better understanding of and improved treatments for human disease.

(ii) Applications of genomics and biotechnology for health, genomics and advances in biotechnology will be exploited by supporting technological platforms for the development of new diagnostic, preventative and therapeutic tools, which will have implications for a wide range of diseases.

(iii) Applications in medicine and public health, there will be a concentration of efforts on cancer, cardiovascular disease, rare diseases and diseases of the nervous system. Furthermore, infectious diseases will be tackled by focusing on combating resistance to drugs.

(iv) Confronting the major communicable diseases linked to poverty, the three major communicable diseases, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), malaria and tuberculosis will be addressed in the context of poverty reduction in developing countries.

Disease-related research is also expected to be covered indirectly in the programme component Anticipating the Community's scientific and technological needs through actions aimed at supporting the Community public health strategy.

Disease-related research is also likely to benefit from the funding proposed for supporting the co-ordination of national research activities under the next Framework Programme.

[Top](#document1)